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Electronic cigarettes are not the only noncigarette prod-
uct associated with increased likelihood of combustible ciga-
rette smoking in AYAs,15 and advertising receptivity was as-
sociated with use of cigars, hookah, and smokeless tobacco in
Pierce et al.1 Similar to e-cigarettes, cigars and hookah are avail-
able in youth-friendly flavors, and their use in the adolescent
population is appreciable.2
Pierce et al1 reinforce what we might expect. We have
known for decades that advertisements for combustible ciga-
rettes and other health-damaging products (eg, high-sugar
foods) are effective in recruiting a new, younger customer base.
The same principles apply to noncigarette tobacco products.
The marketing of such products in youth-friendly flavors or
packaging may enhance the risk of exposure to advertise-
ments that promote use initiation of both noncigarette to-
bacco products and combustible cigarettes, posing a threat to
the public health of this generation of adolescents and young
adults.
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Balancing Parental Needs for Physicians’ Technical Help
With Physicians’ Legal Protection
Amanda Rahman, DO; Shetal Shah, MD; Edmund F. La Gamma, MD
It is a confusing world. Technology advances daily, new knowl-
edge gets disseminated instantly, and somehow everyone must
make sense of it all. But can we, without expert guidance?
While worldly things evolve rapidly, parenting emotions
remain constant. Neonatal intensive care hospitalization is a
stressful experience for medically naive parents who serve as
a proxy for their infants and must make important decisions
with lifelong consequences
on their behalf. Physicians
have a unique and challeng-
ing role in this decision-making process. By virtue of their tech-
nical expertise, knowledge base, and professional duty, phy-
sicians also have a critical role in the lives of these infants. In
the article by Weiss et al1 in this issue of JAMA Pediatrics, the
authors question whether physicians and parents under-
stand each other’s priorities during the process of medical de-
cision making.
Weiss et al1 find that the specific circumstances in which
families choose to retain decision making authority are mat-
ters involving higher risks and long-term outcomes. By con-
trast, decisions thought to have a direct benefit to their child
and any urgent choices are relegated to the physician team. The
report has implications for the informed consent process and
suggests that both parents and physicians should reconsider
the premise of these discussions. Two major questions are
raised. First, how are parents best served by the consent pro-
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cess? Second, under what situations should physicians ob-
tain consent?
Today, consent legally documents patient/surrogate un-
derstanding of the risks and benefits of and alternatives to a
therapy and demonstrates that physicians are acting under the
legal definition of good faith. The article by Weiss et al1 con-
siders how patients and physicians might benefit from a con-
sent process that includes a better understanding of when par-
ents desire to cede control of treatments for their child to the
physician. The article underscores the importance of infor-
mation presentation in consent outcomes and the crucial role
that context plays in counseling parents. For example, if re-
suscitation of a fetus of 23 weeks’ gestational age is presented
as a circumstance in which a high potential of benefit exists,
as opposed to a circumstance with a high likelihood of harm,
parental responses may differ. The resulting clinical ap-
proach may reflect the biases of the medical team rather than
accurate parental preferences.
Traditionally, the spectrum of decision making is a con-
tinuum composed of 2 extremes: a paternalistic model of health
care or an informed decision making process. In the first, the
patient is passive, allowing the physician to assume a more
authoritative role in decision making. In the second, more au-
tonomous model, the physician shares information but does
not share in the decision making.2 The parent, serving as a sur-
rogate of the child patient, is responsible for processing phy-
sician-provided information and drawing a conclusion, which
is then communicated to a physician who acts primarily as an
agent of parental preferences.2
Current perspectives argue for a shared decision making
model. Notably, this has been endorsed by the American Acad-
emy of Pediatrics.3 However, it is likely that clinicians prac-
tice shared decision making less often than we think. Tucker
Edmonds et al4 performed a pilot study of neonatologists’ de-
cision making roles in delivery room resuscitation counsel-
ing for periviable births, a common scenario in a neonatal in-
tensive care unit. The study found that most physicians, even
when explicitly asked what they prefer, continued to give only
objective data and were unable or unwilling to provide a rec-
ommendation on resuscitation. Strikingly, few physicians
asked about the values of the family; in fact, neonatologists
tended to force parental autonomy, even when parents did not
desire it.
Reasons for this behavior are unclear. One interpretation
may be that physicians try to restrain themselves from un-
duly influencing parental decision making and therefore at-
tempt to use data to sanitize an issue from muddying by emo-
tion or personal beliefs. Simply put, the parents may seek
guidance, but the physician is seeking protection from bias and
potential legal insulation. Furthermore, physicians them-
selves may be uncertain or uncomfortable with the weight of
these decisions and use the guise of parental autonomy to hide
their own insecurity.
Weiss et al1 also discuss how implications of decisions
may affect parental involvement. Their findings show par-
ents want to be involved most commonly in decisions that
are highly likely to affect the big picture or in treatment deci-
sions that are potentially dangerous. The authors describe
parental desire for children to survive with the best out-
comes, and the tendency for parents to seek involvement in
decisions that may impair this goal. However, details of how
they achieve this outcome appear less important. To explain
via analogy: an airplane passenger may want the pilot to fly
the plane to London safely, but the altitude of flight is the
pilot’s decision. In neonatal health care settings, the focus is
on the end result of optimal child health, not on clinical
nuances. This is unsettling because physicians often provide
many technical details of a choice instead of eliciting what
parents actually want from the consent process. Conse-
quently, physician weakness may lie in failing to ask what is
important to families, and thus not knowing what decisions
matter most to them.
As we see it, the problem lies not in how to conduct a shared
decision model, but when it should be used. Advocates argue
for using this process when the prospective decision has mul-
tiple options, no clearcut right or wrong choice, and conse-
quences for the well-being of the patient or family.5 In prac-
tice, many routine decisions made by neonatologists fit these
criteria but are not shared (eg, advancing feedings from 30 mL
to 40 mL). The challenge for the clinician remains in gauging
how large, controversial, or influential a decision need to be
before it is necessary to formally involve families. Are we con-
senting for an overall strategic plan, or for all tactical turning
points along the way?
In our opinion, another formidable question is to con-
sider how much decision power clinicians are willing to forgo.
Is it appropriate to surrender all important decisions to incom-
pletely informed lay personnel? What, then, is the meaning of
expert opinion? Shifting the current barometer of decision mak-
ing too far away from medical control by empowering paren-
tal authority over all decisions can have unintended conse-
quences, especially during intensive care interventions.
Consider debates over vaccines causing autism or parental re-
fusal to give vitamin K after birth; these were well-intended
family opinions that were not based on medical facts. In-
deed, these positions may be better characterized as ex-
amples of patient/surrogate autonomy unconstrained by medi-
cal insight and expertise and, perhaps most disturbingly,
exhibiting a lack of trust.
Physicians generally consider the informed consent a le-
gal document, fearing the reality of lawsuits citing absence of
informed consent. As a result, all procedures and many deci-
sions require consent. However, the reality is that the in-
formed consent process becomes cumbersome and often falls
to the bottom of an already busy to-do list. Instead of being
an optimal time to truly discuss goals of care, it becomes a
rushed process to get a form signed, which means it is not al-
ways informative. In her review, Grady comments on the lack
of power of a signature.6 Although we consider written con-
sent necessary to truly consider a patient informed, the real-
ity is that a signature is a superficial marker of an apparent un-
derstanding and agreement.
There may be some middle ground in how medicine navi-
gates 2 polar models of decision making. If parents feel over-
whelmed and incapable of making truly informed decisions,
some may prefer a more paternalistic physician role. Parents
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can also experience guilt in life-or-death decisions and may
desire the physician to make choices, which absolves them
of the burden. We argue that while it is important to provide
parents data, such data only become information when the
physician provides an expert opinion to interpret them and
guide the decision making process. A parental desire to be in-
formed by facts must not be misinterpreted as becoming
knowledgeable enough to have an expert opinion on a com-
plex topic that they were not trained to manage.
While it may be a long time before we alter the legacy of
consenting (or continue making it more complex), the study
by Weiss et al1 serves the purpose of focusing attention on the
topic by providing patient perspective. The study by Weiss et
al1 reminds us that communication with families will con-
tinue to be a challenge in the neonatal intensive care unit as
patient expectations of autonomy continue to expand and pa-
ternalism diminishes in health care. Because a little knowl-
edge can be dangerous, awakening this issue both hinders and
helps with the challenge of optimal medical decision making,
including a requirement for improved health literacy in our
patient population. The solution lies not only in providing
black-and-white data, but also in wisely working with par-
ents to identify a shared goal, work toward that goal, and de-
termine which components of care need discussion.
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Should Pediatricians Be More Proactive in Counseling
Children About Skin Cancer Risk?
Implications of the USPSTF Recommendation Statement
Robert Sidbury, MD, MPH
The most recent issue of JAMA includes the updated recom-
mendation statement from the US Preventive Services Task
Force (USPSTF) on behavioral counseling to prevent skin
cancer.1 In the same issue is the supporting evidence report and
systematic review.2 The rec-
ommendations differ nota-
bly from the 2012 iteration3 in
the following ways: (1) coun-
seling for persons with fair skin types is now recommended as
early as age 6 months, down from age 10 years; and (2) selec-
tive counseling is now recommended for adults older than 24
years with fair skin types. The first of these new recommen-
dations is already well known to pediatricians. Intervening early
with parents and appropriate-age children likely helps to shape
safe future behaviors and decrease skin cancer risks; not do-
ing so will leave those same children, conditioned to bad hab-
its over the span of their youth, relatively refractory to later edu-
cation. A broad coalition of stakeholders has endorsed this
guidance, including the American Cancer Society,4 the Royal
Australian College of General Physicians,5 the American Acad-
emy of Pediatrics,6 the American Academy of Dermatology,7
and others.
Nonetheless, these recommendation updates from the
Task Force are important to pediatricians for several reasons.
First, skin cancer is the most common type of cancer in the
United States, and it is increasing in frequency.8 Melanoma is
the second leading cause of death in patients aged 15 to 25
years.9 In my own residency training in the 1990s, I was taught
that a child born in the United States had a 1 in 70 chance of
developing malignant melanoma. I teach my own residents to-
day that that same risk is closer to 1 in 40. Encouragingly, re-
cent trends have identified a modest decline in pediatric mela-
noma incidence from 2004 through 2010 after years of 2% to
3% annual increases.10
Second, the strongest connection between UV radiation
(UVR) exposure and skin cancer is in childhood and adoles-
cence. For most individuals, the majority of lifetime UVR ex-
posure occurs prior to age 18 years. There is also some evi-
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